These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies. Li X, Wang L, Yu J, Xu J, Du J. Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019 [Abstract] [Full Text] [Related]
14. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. Zhang J, Huang X, Xiao J, Yang Y, Zhou Y, Wang X, Liu Q, Yang J, Wang M, Qiu L, Zheng Y, Zhang P, Li J, Wang Y, Wei Q, Jin L, Wang J, Wang M. PLoS One; 2014 Dec; 9(6):e100055. PubMed ID: 24945256 [Abstract] [Full Text] [Related]
15. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population. Yang C, Ma X, Liu D, Wang Y, Tang R, Zhu Y, Xu Z, Yang L. Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020 [Abstract] [Full Text] [Related]
16. Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features. Heidari Z, Mohammadpour-Gharehbagh A, Eskandari M, Harati-Sadegh M, Salimi S. J Cell Biochem; 2019 May; 120(5):8640-8647. PubMed ID: 30552691 [Abstract] [Full Text] [Related]
19. Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls. Tao T, Chen S, Xu B, Liu C, Wang Y, Huang Y, Chen M. Chin J Cancer Res; 2014 Jun; 26(3):315-22. PubMed ID: 25035659 [Abstract] [Full Text] [Related]
20. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Li L, Wu J, Sima X, Bai P, Deng W, Deng X, Zhang L, Gao L. Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554 [Abstract] [Full Text] [Related] Page: [Next] [New Search]